middle.news
EMVision Advances Brain Scanner Trials and Secures $17.1m Cash Reserves
9:20am on Wednesday 15th of July, 2026 AEST
•
Healthcare
Read Story
EMVision Advances Brain Scanner Trials and Secures $17.1m Cash Reserves
9:20am on Wednesday 15th of July, 2026 AEST
Key Points
Pivotal trial surpasses enrolment milestones
Acute ischaemia detection endpoint planned
Successful aeromedical feasibility study completed
Peer-reviewed validation of AI technology published
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Emvision Medical Devices (ASX:EMV)
OPEN ARTICLE